Sartorius Stedim Biotech S.A. (EPA:DIM)

Sartorius Stedim Biotech Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 6, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	21,989	20,433	18,363	22,073	27,883	44,467
Market Cap Growth	16.58%	11.28%	-16.81%	-20.84%	-37.29%	65.66%
Enterprise Value	24,140	22,733	20,749	25,782	28,964	44,979
Last Close Price	225.80	209.15	187.23	237.01	297.92	473.53

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 6, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	67.86	76.93	104.87	71.14	31.83	107.31
Forward PE	39.00	40.98	46.49	49.64	31.48	60.28
PS Ratio	7.18	6.89	6.61	7.95	7.98	15.40
PB Ratio	5.00	4.95	4.56	8.26	11.09	25.66
P/TBV Ratio	36615.89	-	-	-	46.41	163.54
P/FCF Ratio	55.60	68.34	38.63	80.91	153.46	117.67
P/OCF Ratio	29.52	29.52	22.53	29.57	45.54	63.35
PEG Ratio	2.41	1.86	2.29	6.24	1.67	6.53

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 6, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	7.88	7.66	7.46	9.29	8.29	15.58
EV/EBITDA Ratio	28.08	29.22	32.97	39.20	24.20	43.61
EV/EBIT Ratio	41.22	42.25	52.40	54.93	27.47	48.88
EV/FCF Ratio	61.05	76.03	43.65	94.51	159.41	119.02

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 6, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.53	0.63	0.71	1.38	0.45	0.36
Debt / EBITDA Ratio	2.68	3.23	4.38	5.39	0.93	0.60
Debt / FCF Ratio	5.85	8.69	6.04	13.50	6.25	1.66
Net Debt / Equity Ratio	0.49	0.53	0.54	1.33	0.40	0.23
Net Debt / EBITDA Ratio	2.56	2.78	3.47	5.41	0.84	0.38
Net Debt / FCF Ratio	5.41	7.24	4.59	13.03	5.52	1.03
Asset Turnover	0.39	0.37	0.35	0.43	0.78	0.85
Inventory Turnover	2.30	2.36	2.01	1.62	1.85	2.13
Quick Ratio	0.46	0.47	1.05	0.49	0.53	0.59
Current Ratio	1.22	1.02	1.85	1.51	1.61	1.40
Return on Equity (ROE)	7.69%	6.53%	5.33%	12.05%	41.43%	25.94%
Return on Assets (ROA)	4.61%	4.14%	3.10%	4.59%	14.62%	16.90%
Return on Invested Capital (ROIC)	6.49%	6.14%	5.19%	7.49%	29.10%	28.75%
Return on Capital Employed (ROCE)	8.50%	8.20%	5.40%	6.90%	26.20%	31.60%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 6, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	1.47%	1.30%	0.95%	1.41%	3.14%	0.93%
FCF Yield	1.80%	1.46%	2.59%	1.24%	0.65%	0.85%
Dividend Yield	0.31%	0.33%	0.37%	0.29%	0.48%	0.26%
Payout Ratio	20.72%	25.26%	38.32%	42.77%	13.25%	15.13%
Buyback Yield / Dilution	0.14%	-0.54%	-5.01%	0.00%	0.01%	0.00%
Total Shareholder Return	0.45%	-0.21%	-4.64%	0.29%	0.49%	0.26%

Data Source: S&P Global Market Intelligence Last updated: Oct 22, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 8, 2026

Data Sources Report a data error